Detalhe da pesquisa
1.
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
Front Immunol;
13: 1050250, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36713447